Five research publications on antimicrobial resistance (AMR) have been released by APC Microbiome Ireland. These publications center on the impacts of routine dry cow medication and the ramifications of early-life antibiotic use. In 2018, the APC AMR Ph.D. The fellowship program recruited Dr. Dhrati Patangia, a recent Ph.D. graduate from the APC and School of Microbiology, University College Cork.
Multi-drug resistance may result from the early exposure of infants to some antibiotics, according to a recent article published in Microbiome. According to a second study that was published in Antibiotics, using antibiotics with routine dry cow therapy is not beneficial. The impact of location, age, and socioeconomic status on the newborn gut resistome is covered in a third publication that was published in Gut Microbes.
Along with discussing the negative consequences of antibiotics on host health and the human microbiome, Dr. Patangia is also the primary author of two reviews, one published in Trends in Microbiology and the other in Microbiology Open. The reviews offer alternatives to antibiotic use. The APC Antimicrobial Resistance Ph.D. The fellowship program aims to teach a group of Ph.D. students with specific research abilities to form an expert cohort of AMR researchers, according to APC Director Professor Paul Ross.
The Organization for Economic Cooperation predicts that by 2035, there will be a twofold increase in antibiotic resistance to last-resort medications compared to 2005 levels, making AMR a major worldwide concern. The director general of Science Foundation Ireland, Professor Philip Nolan, complimented APC and Dr. Patangia on their latest scientific findings that will help us understand antimicrobial resistance and find better solutions to it. According to Professor John F. Cryan, UCC Vice President for Research & Innovation, UCC scientists at APC are leading vital research in the field of microbiome research to tackle global AMR issues.
More news on How beneficial are apps for mental health?